Literature DB >> 2855601

Detection of novel non-ras oncogenes in rat nasal squamous cell carcinomas.

A E Hochwalt1, I Wirgin, M Felber, D D Currie, S J Garte.   

Abstract

Rat nasal squamous cell carcinomas induced by inhalation of three direct-acting alkylating agents yielded DNA containing activated oncogenes with no homology to any member of the ras family. The novel NIH 3T3 transforming oncogenes from tumors induced by beta-propiolactone and methylmethane sulfonate are distinct from each other based on restriction analysis. The gene isolated from beta-propiolactone-induced tumors is between 6 and 9 kb in size. None of the tumors induced by dimethylcarbamyl chloride contained positive DNA in the NIH 3T3 focus assay or in the nude mouse cotransfection assay. The rat nasal tumor model is apparently ideally suited for analysis of the roles of carcinogen and tissue specificity in oncogene activation, especially related to novel (non-ras) transforming oncogenes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2855601     DOI: 10.1002/mc.2940010104

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  4 in total

1.  Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses.

Authors:  Joost P Uittenbogaard; Bert Zomer; Peter Hoogerhout; Bernard Metz
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

2.  Oncogene activation in experimental carcinogenesis: the role of carcinogen and tissue specificity.

Authors:  S J Garte; A E Hochwalt
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

Review 3.  Oncogenes and radiation carcinogenesis.

Authors:  S J Garte; F J Burns
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 4.  Role of proto-oncogene activation in carcinogenesis.

Authors:  M W Anderson; S H Reynolds; M You; R M Maronpot
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.